Reported Dec 31, 2014 · Terminated
Benzonatate Capsules, USP, 100 mg, Rx only, Manufactured by
Zydus Pharmaceuticals USA Inc.
Moderate riskThis product could cause temporary or reversible health problems — stop using it.What you should do
Stop using the affected lot and contact the recalling firm for the return or refund process. Check the FDA enforcement report for lot-level detail.
Firm contact: Zydus Pharmaceuticals USA Inc · 73 Route 31 N · Pennington, NJ · 08534-3601
Is this the product you have?
Benzonatate Capsules, USP, 100 mg, Rx only, Manufactured by
3 of 3 products
| # | Product as published |
|---|---|
| 1 | Cadila Healthcare Ltd, Ahmedabad, India |
| 2 | Distributed by: Zydus Pharmaceuticals USA, In, Pennington, NJ USA 08534 |
| 3 | 100-bottle capsules - NDC 68382-247-01 500-bottle capsules - NDC 68382-247-05 |
- Lot codes and dates
Lot #: MP2625MP2626MP2627 Exp 2/16MP4875MP4876MP4877MP4878 Exp 4/16MP6482MP6483MP6484MP6493MP6494 Exp 6/16
- Amount recalled
- 19,536 units
Where it was sold
- Nationwide
Why it was recalled
Failed Tablet/Capsule Specifications: Recall due to wet and/or leaking capsules.
This product could cause temporary or reversible health problems — stop using it.
Want the full recall guide?
The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.
Free recall alerts
Get alerted about new Zydus Pharmaceuticals USA Inc. recalls
One email when a matching recall is published. No account, no cost, unsubscribe in one click.
We email you about recalls and nothing else. Every send has a one-click unsubscribe, and you can change your preferences any time without an account.